Treatment of ascites and renal failure in cirrhosis.

[1]  M. Labianca,et al.  Titanium catheter tip for peritoneovenous shunts. , 2008, Artificial organs.

[2]  T. Reynolds,et al.  Effect of Inhibitors of Prostaglandin Synthesis On Induced Diuresis in Cirrhosis , 2007, Hepatology.

[3]  N. Christensen,et al.  Sympathetic Nervous Activity and Renal and Systemic Hemodynamics in Cirrhosis: Plasma Norepinephrine Concentration, Hepatic Extraction, and Renal Release , 2007, Hepatology.

[4]  J. Llach,et al.  Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. , 1988, Gastroenterology.

[5]  V. Arroyo,et al.  Prostaglandin precursor fatty acids in cirrhosis with ascites: effect of linoleic acid infusion in functional renal failure. , 1988, Clinical science.

[6]  F. Lang.  Physiology of diuretic action. , 1988, Renal physiology.

[7]  M. Epstein,et al.  Management of Renal Complications of Liver Disease , 1988 .

[8]  J. Llach,et al.  Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. , 1988, Gastroenterology.

[9]  W. Jiménez,et al.  Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. , 1987, Gastroenterology.

[10]  C. Nast,et al.  Immunohistochemical distribution of renal prostaglandin endoperoxide synthase and prostacyclin synthase: Diminished endoperoxide synthase in the hepatorenal syndrome , 1987, Hepatology.

[11]  H. Bonkovsky,et al.  Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function , 1987, Hepatology.

[12]  E. Moore,et al.  Peritoneovenous shunt in the management of the hepatorenal syndrome. , 1986, Kidney international.

[13]  T. Reynolds,et al.  Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema. , 1986, Gastroenterology.

[14]  N. Christensen,et al.  Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture. , 1986, British medical journal.

[15]  F. Guarner,et al.  Renal prostaglandins in cirrhosis of the liver. , 1986, Clinical science.

[16]  F. Trevisani,et al.  Effects of a new loop diuretic (muzolimine) in cirrhosis with ascites: Comparison with furosemide , 1986, Hepatology.

[17]  J. Henderson,et al.  LeVeen vs Denver peritoneovenous shunts for intractable ascites of cirrhosis. A randomized, prospective trial. , 1986, Archives of surgery.

[18]  G. Ciabattoni,et al.  Altered renal and platelet arachidonic acid metabolism in cirrhosis. , 1986, Gastroenterology.

[19]  F. Trevisani,et al.  Renal function impairment induced by change in posture in patients with cirrhosis and ascites. , 1985, Gut.

[20]  T. Reynolds,et al.  The effect of large volume paracentesis on plasma volume—A cause of hypovolemia? , 1985, Hepatology.

[21]  V. Arroyo,et al.  PARACENTESIS VERSUS DIURETICS IN THE TREATMENT OF CIRRHOTICS WITH TENSE ASCITES , 1985, The Lancet.

[22]  Klamer Tw,et al.  Peritoneovenous shunts: predictive factors of early treatment failure. , 1984 .

[23]  D. Franco.  [Treatment of intractable ascites in cirrhotic patients by portal shunt]. , 1983, Gastroenterologie clinique et biologique.

[24]  J. Henriksen,et al.  Peritoneovenous shunt in treatment of ascites in patients with cirrhosis. A preliminary report with special reference to pathophysiology. , 1983, Scandinavian journal of gastroenterology.

[25]  V. Arroyo,et al.  Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites: Relationship between the diuretic response and the activity of the renin-aldosterone system , 1983 .

[26]  J. Perkin,et al.  Coagulopathy of peritoneovenous shunts: studies on the pathogenic role of ascitic fluid collagen and value of antiplatelet therapy. , 1983, Gut.

[27]  R. Reznick,et al.  Hyponatremia and arginine vasopressin secretion in patients with refractory hepatic ascites undergoing peritoneovenous shunting , 1983 .

[28]  V. Arroyo,et al.  Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites. , 1983, Gastroenterology.

[29]  M. Epstein,et al.  Augmentation of prostaglandin production by linoleic acid in man. , 1982, Clinical science.

[30]  W. Turner,et al.  The Denver Peritoneovenous shunt: relationship between hepatic reserve and successful treatment of ascites. , 1982, American journal of surgery.

[31]  S. Heymsfield,et al.  Hemodynamics of LeVeen Shunt Pulmonary Edema , 1981, Annals of surgery.

[32]  R. Casamitjana,et al.  Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level. , 1980, Gut.

[33]  A. Attallah.  Interaction of prostaglandins with diuretics. , 1979, Prostaglandins.

[34]  S. Wapnick,et al.  Randomized prospective matched pair study comparing peritoneovenous shunt and conventional therapy in massive ascites , 1979, The British journal of surgery.

[35]  T. Reynolds,et al.  Effect of indomethacin and prostaglandin A, on renal function and plasma renin activity in alcoholic liver disease , 1979 .

[36]  A. Straus,et al.  Hemorrhage from esophageal varices after placement of the LeVeen shunt. , 1979, Gastroenterology.

[37]  E. Williams.  Exercise and altitude. , 1979, Postgraduate medical journal.

[38]  J. Hoefs,et al.  Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease. , 1979, The Journal of clinical endocrinology and metabolism.

[39]  P. Gabow,et al.  Spironolactone-induced hyperchloremic acidosis in cirrhosis. , 1979, Annals of internal medicine.

[40]  E. Rosato,et al.  Improved renal function and inhibition of renin and aldosterone secretion following peritoneovenous (LeVeen) shunt. , 1978, Surgery.

[41]  Gussin Rz.  Potassium-sparing diuretics. , 1977 .

[42]  Reinhardt Gf,et al.  Peritoneovenous shunting for ascites. , 1977 .

[43]  M. Weston,et al.  Dialysis in the treatment of renal failure in patients with liver disease. , 1977, Clinical nephrology.

[44]  I. Broeckaert,et al.  Demeclocycline Treatment of Water Retention in Cirrhosis , 1976 .

[45]  F. Vilardell,et al.  Clinical experience with the Rhône-Poulenc ascites reinfusion apparatus , 1975, Postgraduate medical journal.

[46]  J. Henderson,et al.  Ascites reinfusion using the Rhodiascit apparatus—clinical experience and coagulation abnormalities , 1975, Postgraduate medical journal.

[47]  V. Arroyo,et al.  A rational approach to the treatment of ascites , 1975, Postgraduate medical journal.

[48]  V. Arroyo,et al.  Clinical types and drug therapy of renal impairment in cirrhosis , 1975, Postgraduate medical journal.

[49]  S. Sherlock,et al.  Use of bumetanide in the treatment of ascites due to liver disease , 1974, Gut.

[50]  H. Leveen,et al.  Peritoneo‐Venous Shunting for Ascites , 1974, Annals of surgery.

[51]  T. Reynolds,et al.  Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites. , 1970, Gastroenterology.

[52]  R. Eggert.  Spironolactone Diuresis in Patients with Cirrhosis and Ascites , 1970, British medical journal.

[53]  L. Shear,et al.  Compartmentalization of ascites and edema in patients with hepatic cirrhosis. , 1970, The New England journal of medicine.

[54]  W. Baldus,et al.  Effects of dopamine on renal function in patients with cirrhosis. , 1970, Gastroenterology.

[55]  T. Reynolds,et al.  Functional renal failure with cirrhosis. The effect of plasma expansion therapy. , 1967, Medicine.

[56]  J. G. Walker,et al.  Complications of diuretic therapy in hepatic cirrhosis. , 1966, Lancet.

[57]  T. Reynolds,et al.  The use of ethacrynic acid in patients with cirrhosis and ascites. , 1965, Gastroenterology.

[58]  J. Kleinerman,et al.  RENAL FAILURE IN PATIENTS WITH CIRRHOSIS OF THE LIVER. I. CLINICAL AND PATHOLOGIC CHARACTERISTICS. , 1965, The American journal of medicine.

[59]  S. Bruno,et al.  Repeated paracentesis and i.v. albumin infusion to treat 'tense' ascites in cirrhotic patients. A safe alternative therapy. , 1987, Journal of hepatology.

[60]  L. Blendis,et al.  The effect of peritoneovenous shunting on catecholamine metabolism in patients with hepatic ascites , 1987, Hepatology.

[61]  M. Bourel,et al.  The treatment of refractory ascites by the LeVeen shunt. A multi-centre controlled trial (57 patients). , 1986, Journal of hepatology.

[62]  V. Arroyo,et al.  Urinary excretion of 6-keto-prostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome). , 1986, Journal of hepatology.

[63]  W. Jiménez,et al.  Effect of demeclocycline on renal function and urinary prostaglandin E2 and kallikrein in hyponatremic cirrhotics. , 1984, Nephron.

[64]  V. Arroyo,et al.  Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites , 1983 .

[65]  L. Blendis,et al.  Renal and hemodynamic effects of the peritoneovenous shunt. II. Long-term effects. , 1981, Gastroenterology.

[66]  L. Blendis,et al.  Complications after peritoneovenous shunting for ascites. , 1980, American journal of surgery.

[67]  H. Smulyan,et al.  Effects of a portacaval or peritoneovenous shunt on renin in the hepatorenal syndrome. , 1979, Kidney international.

[68]  A. Aho,et al.  Effect of oxygen ventilation in mesenteric arterial occlusion in the dog. , 1972, Scandinavian journal of gastroenterology.

[69]  P. Talso,et al.  Paradoxical hyponatremia associated with congestive heart failure and with cirrhosis of the liver. , 1956, Metabolism: clinical and experimental.